Figure 3From: Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic MiceGalantamine administration reduces levels of circulating pathogenic anti-insulin antibodies. Serum from galantamine- or saline-administered was applied to ELISA plates coated with antigens and then probed with anti-mouse antibodies. Serum anti-insulin antibodies were reduced in animals administered galantamine (A) (p > 0.05), but other common NOD autoantibodies were not affected (B–E).Back to article page